BlueView

At Helmer Scientific, we are looking forward to our 41st consecutive year of exhibiting at the AABB Annual Meeting. Come visit our virtual booth during the online event, to be held October 3-5, 2020.

There have been several recent developments regarding the use of convalescent plasma as a treatment for COVID-19. The U.S. Food & Drug Administration (FDA) issued an emergency use authorization for COVID-19 convalescent plasma (CCP) in August 2020. Subsequently, the FDA...

The U.S. Food and Drug Administration (FDA) released its guidance document entitled “Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion” several months ago. Since...

Reliable platelet storage is essential to blood centers and hospital transfusion services. Blood banks constantly face the challenge of making sure enough platelets are available to meet patient needs. This means it is essential to have a platelet storage system that users...

Platelet products must be stored within a precise temperature range and with continuous agitation. They have a very limited shelf life. Blood suppliers invest a great deal of resources to collect, manufacture, and deliver platelet products to hospitals.

Blood banks can be noisy environments. With constant background noise from various pieces of equipment, plus different alarm tones and pagers activating inside the laboratory, the sound level can create challenges for staff. 

During the early stages of the COVID-19 pandemic, the blood supply dropped to a critical level. At that time, the blood community issued public statements encouraging eligible individuals to donate. Thanks to a strong response from the public, the blood supply was replenished...

Healthcare facilities are under increased pressure to ensure consistent and reliable refrigeration for the storage of temperature sensitive medications, vaccines, reagents, and patient samples. There are significant implications when a refrigerator used for clinical...

COVID-19 Convalescent Plasma, or CCP, is being transfused as an investigational therapy for patients fighting the novel coronavirus. While its efficacy has not yet been determined, a small study recently indicated it is showing promise as a treatment option.

In 2019 AABB launched the Standards-Compliant Product Evaluation (SCoPE) Program for vendors that serve the transfusion medicine community. The program was developed to recognize suppliers that demonstrate compliance with AABB Standards.